Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Indian Science
  4. Volume 1, Issue 1
  5. Article
Volume 1, Issue 1
  • ISSN: 2210-299X
  • E-ISSN: 2210-3007
file format text download EPUB
file format pdf download PDF
side by side viewer icon HTML

Abstract

Among the inorganic elements, selenium is one of the essential entities required in trace amounts. Selenium (Se) has a vital role to play in brain physiology. It is well demonstrated that an abnormal level of selenium is the cause of the pathogenesis of various neurodegenerative diseases. As selenium levels are age-dependent, deficiency of Se is well correlated with cognitive disability with aging, which further correlates with Alzheimer’s disease. Organoselenium compounds are considered an essential therapeutic class of compounds as they have gained a wide spectrum of applications in biotransformation and are well-studied by several researchers. In recent years, a detailed analysis of the effectiveness of organoselenium compounds in attenuating disease are done. A literature search on PubMed, Embase, and Scopus databases was done using the keywords “organoselenium compounds, brain disorder, Alzheimer's, Parkinson's' disease, and neurodegenerative disorders. The introduction of selenium as a functional group in aryl and heteroaryl compounds has given the lead for treating various brain ailments including Alzheimer's disease, depression, anxiety, Parkinson’s disease, . The organoselenium compounds are also potent antioxidants and are promising chemical entities for further studies.

© 2023 Bentham Science Publishers
© 2023 The Author(s). Published by Bentham Science Publisher. This is an open access article published under CC BY 4.0 https://creativecommons.org/licenses/by/4.0/legalcode
Loading

Article metrics loading...

/content/journals/cis/10.2174/2210299X02666221027151154
2023-01-01
2024-11-22

  • From This Site

    /content/journals/cis/10.2174/2210299X02666221027151154
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

/deliver/fulltext/cis/1/1/CIS-1-E271022210428.html?itemId=/content/journals/cis/10.2174/2210299X02666221027151154&mimeType=html&fmt=ahah

References

  1. NinomiyaM. GarudD.R. KoketsuM. Biologically significant selenium-containing heterocycles.Coord. Chem. Rev.201125523-242968299010.1016/j.ccr.2011.07.009
     [Google Scholar]
  2. StadtmanT.C. Selenoproteins-tracing the role of a trace element in protein function.PLoS Biol.2005312e42110.1371/journal.pbio.003042116336050
     [Google Scholar]
  3. RotruckJ.T. PopeA.L. GantherH.E. SwansonA.B. HafemanD.G. HoekstraW.G. Selenium: Biochemical role as a component of glutathione peroxidase.Science1973179407358859010.1126/science.179.4073.5884686466
     [Google Scholar]
  4. BöckA. ForchhammerK. HeiderJ. LeinfelderW. SawersG. VeprekB. ZinoniF. Selenocysteine: The 21st amino acid.Mol. Microbiol.19915351552010.1111/j.1365‑2958.1991.tb00722.x1828528
     [Google Scholar]
  5. NarajjiC. KarvekarM.D. DasA.K. Biological importance of organoselenium-compounds Indian.J. Pharm. Sci.2007693344
     [Google Scholar]
  6. MukherjeeA.J. ZadeS.S. SinghH.B. SunojR.B. Organoselenium chemistry: Role of intramolecular interactions.Chem. Rev.201011074357441610.1021/cr900352j20384363
     [Google Scholar]
  7. VincetiM. FilippiniT. Del GiovaneC. DennertG. ZwahlenM. BrinkmanM. ZeegersM.P. HorneberM. D’AmicoR. CrespiC.M. Selenium for preventing cancer.Cochrane Database Syst. Rev.20181CD00519529376219
     [Google Scholar]
  8. GandinV. KhalkarP. BraudeJ. FernandesA.P. Organic selenium compounds as potential chemotherapeutic agents for improved cancer treatment.Free Radic. Biol. Med.2018127809710.1016/j.freeradbiomed.2018.05.00129746900
     [Google Scholar]
  9. Hatfield, D.L.; Berry, M.J.; Gladyshev, V.N., Eds.; Selenium: its molecular biology and role in human health; Springer Science & Business Media, 2011.
  10. CardosoBR HareDJ BushAI The Role of Selenium in Neurodegenerative Diseases.Biometals in Neurodegenerative Diseases: Mechanisms and Therapeutics2017354910.1016/B978‑0‑12‑804562‑6.00003‑8
     [Google Scholar]
  11. HassanW.S. OliveiraC. NoreenH.P. KamdemJ. NogueiraC. RochaJ. Organoselenium compounds as potential neuroprotective therapeutic agents.Curr. Org. Chem.201620221823110.2174/1385272819666150810222632
     [Google Scholar]
  12. ChenJ. BerryM.J. Selenium and selenoproteins in the brain and brain diseases.J. Neurochem.200386111210.1046/j.1471‑4159.2003.01854.x12807419
     [Google Scholar]
  13. RomanM. JitaruP. BarbanteC. Selenium biochemistry and its role for human health.Metallomics201461255410.1039/C3MT00185G24185753
     [Google Scholar]
  14. SanmartínC. PlanoD. FontM. PalopJ.A. Selenium and clinical trials: New therapeutic evidence for multiple diseases.Curr. Med. Chem.201118304635465010.2174/09298671179737924921864284
     [Google Scholar]
  15. ParnhamM.J. SiesH. The early research and development of ebselen.Biochem. Pharmacol.20138691248125310.1016/j.bcp.2013.08.02824012716
     [Google Scholar]
  16. DominiakA. WilkaniecA. WroczyńskiP. AdamczykA. Selenium in the therapy of neurological diseases. Where is it going?Curr. Neuropharmacol.201614328229910.2174/1570159X1466615122310001126549649
     [Google Scholar]
  17. RaymanM.P. The importance of selenium to human health.Lancet2000356922523324110.1016/S0140‑6736(00)02490‑910963212
     [Google Scholar]
  18. GirekM. SzymańskiP. Tacrine hybrids as multi-target-directed ligands in Alzheimer’s disease: Influence of chemical structures on biological activities.Chem. Pap.201973226928910.1007/s11696‑018‑0590‑8
     [Google Scholar]
  19. DuX. WangC. LiuQ. Potential roles of selenium and selenoproteins in the prevention of Alzheimer’s disease.Curr. Top. Med. Chem.201516883584810.2174/156802661566615082709493626311427
     [Google Scholar]
  20. Di LeoI. SancinetoL. MessinaF. SantiC. Organoselenium compounds, an overview on the biological activities beyond antioxidant properties.Proceedings of The 20th International Electronic Conference on Synthetic Organic ChemistryNovember 01-30, 2016MDPI: Basel, Switzerland10.3390/ecsoc‑20‑b018
     [Google Scholar]
  21. ZhangZ.H. SongG.L. Roles of selenoproteins in brain function and the potential mechanism of selenium in Alzheimer’s disease.Front. Neurosci.20211564651810.3389/fnins.2021.64651833762907
     [Google Scholar]
  22. CardosoB.R. RobertsB.R. BushA.I. HareD.J. Selenium, selenoproteins and neurodegenerative diseases.Metallomics2015781213122810.1039/C5MT00075K25996565
     [Google Scholar]
  23. SunX ChenWD WangYD β-Amyloid: the key peptide in the pathogenesis of Alzheimer's disease.Front Pharmacol.2015622110.3389/fphar.2015.00221
     [Google Scholar]
  24. HaratakeM. YoshidaS. MandaiM. FuchigamiT. NakayamaM. Elevated amyloid-β plaque deposition in dietary selenium-deficient Tg2576 transgenic mice.Metallomics20135547948310.1039/c3mt00035d23456036
     [Google Scholar]
  25. LuoZ. LiangL. ShengJ. PangY. LiJ. HuangL. LiX. Synthesis and biological evaluation of a new series of ebselen derivatives as glutathione peroxidase (GPx) mimics and cholinesterase inhibitors against Alzheimer’s disease.Bioorg. Med. Chem.20142241355136110.1016/j.bmc.2013.12.06624461494
     [Google Scholar]
  26. MartiniF. PesaricoA.P. BrüningC.A. ZeniG. NogueiraC.W. Ebselen inhibits the activity of acetylcholinesterase globular isoform G4 in vitro and attenuates scopolamine‐induced amnesia in mice.J. Cell. Biochem.201811975598560810.1002/jcb.2673129405440
     [Google Scholar]
  27. MartiniF. RosaS.G. KlannI.P. FulcoB.C.W. CarvalhoF.B. RahmeierF.L. FernandesM.C. NogueiraC.W. A multifunctional compound ebselen reverses memory impairment, apoptosis and oxidative stress in a mouse model of sporadic Alzheimer’s disease.J. Psychiatr. Res.201910910711710.1016/j.jpsychires.2018.11.02130521994
     [Google Scholar]
  28. WangZ. WangY. LiW. MaoF. SunY. HuangL. LiX. Design, synthesis, and evaluation of multitarget-directed selenium-containing clioquinol derivatives for the treatment of Alzheimer’s disease.ACS Chem. Neurosci.201451095296210.1021/cn500119g25121395
     [Google Scholar]
  29. WangZ. LiW. WangY. LiX. HuangL. LiX. Design, synthesis and evaluation of clioquinol–ebselen hybrids as multi-target-directed ligands against Alzheimer’s disease.RSC Advances2016697139715810.1039/C5RA26797H
     [Google Scholar]
  30. TinG MohamedT GondoraN BeazelyMA RaoPP Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease.Med. Chem Comm.20156111930194110.1039/C5MD00274E
     [Google Scholar]
  31. BarbosaF.A.R. CantoR.F.S. SabaS. RafiqueJ. BragaA.L. Synthesis and evaluation of dihydropyrimidinone-derived selenoesters as multi-targeted directed compounds against Alzheimer’s disease.Bioorg. Med. Chem.201624225762577010.1016/j.bmc.2016.09.03127681239
     [Google Scholar]
  32. PeglowT.J. SchumacherR.F. CargneluttiR. ReisA.S. LucheseC. WilhelmE.A. PerinG. Preparation of bis(2-pyridyl) diselenide derivatives: Synthesis of selenazolo[5,4-b]pyridines and unsymmetrical diorganyl selenides, and evaluation of antioxidant and anticholinesterasic activities.Tetrahedron Lett.201758383734373810.1016/j.tetlet.2017.08.030
     [Google Scholar]
  33. MeinerzD.F. de PaulaM.T. ComparsiB. SilvaM.U. SchmitzA.E. BragaH.C. TaubeP.S. BragaA.L. RochaJ.B.T. DafreA.L. FarinaM. FrancoJ.L. PosserT. Protective effects of organoselenium compounds against methylmercury-induced oxidative stress in mouse brain mitochondrial-enriched fractions.Braz. J. Med. Biol. Res.201144111156116310.1590/S0100‑879X201100750013622002094
     [Google Scholar]
  34. PintonS. da RochaJ.T. ZeniG. NogueiraC.W. Organoselenium improves memory decline in mice: Involvement of acetylcholinesterase activity.Neurosci. Lett.20104721566010.1016/j.neulet.2010.01.05720122991
     [Google Scholar]
  35. PintonS. SouzaA.C. SariM.H.M. RamalhoR.M. RodriguesC.M.P. NogueiraC.W. p,p′-Methoxyl-diphenyl diselenide protects against amyloid-β induced cytotoxicity in vitro and improves memory deficits in vivo.Behav. Brain Res.201324724124710.1016/j.bbr.2013.03.03423557695
     [Google Scholar]
  36. DuarteL.F.B. OliveiraR.L. RodriguesK.C. VossG.T. GodoiB. SchumacherR.F. PerinG. WilhelmE.A. LucheseC. AlvesD. Organoselenium compounds from purines: Synthesis of 6-arylselanylpurines with antioxidant and anticholinesterase activities and memory improvement effect.Bioorg. Med. Chem.201725246718672310.1016/j.bmc.2017.11.01929157728
     [Google Scholar]
  37. PinzM.P. dos ReisA.S. VogtA.G. KrügerR. AlvesD. JesseC.R. RomanS.S. SoaresM.P. WilhelmE.A. LucheseC. Current advances of pharmacological properties of 7-chloro-4-(phenylselanyl) quinoline: Prevention of cognitive deficit and anxiety in Alzheimer’s disease model.Biomed. Pharmacother.20181051006101410.1016/j.biopha.2018.06.04930021335
     [Google Scholar]
  38. van EerselJ. KeY.D. LiuX. DelerueF. KrilJ.J. GötzJ. IttnerL.M. Sodium selenate mitigates tau pathology, neurodegeneration, and functional deficits in Alzheimer’s disease models.Proc. Natl. Acad. Sci.201010731138881389310.1073/pnas.100903810720643941
     [Google Scholar]
  39. Chiapinotto SpiazziC. Bucco SoaresM. Pinto IzaguirryA. Musacchio VargasL. ZanchiM.M. Frasson PavinN. Ferreira AffeldtR. Seibert LüdtkeD. PrigolM. SantosF.W. Selenofuranoside ameliorates memory loss in Alzheimer-like sporadic dementia: AChE activity, oxidative stress, and inflammation involvement.Oxid. Med. Cell. Longev.201520151910.1155/2015/976908
     [Google Scholar]
  40. XieY. LiuQ. ZhengL. WangB. QuX. NiJ. ZhangY. DuX. Se‐methylselenocysteine ameliorates neuropathology and cognitive deficits by attenuating oxidative stress and metal dyshomeostasis in Alzheimer model mice.Mol. Nutr. Food Res.20186212180010710.1002/mnfr.20180010729688618
     [Google Scholar]
  41. ZamberlanD.C. ArantesL.P. MachadoM.L. GolombieskiR. SoaresF.A.A. Diphenyl-diselenide suppresses amyloid-β peptide in Caenorhabditis elegans model of Alzheimer’s disease.Neuroscience2014278405010.1016/j.neuroscience.2014.07.06825130558
     [Google Scholar]
  42. YanJ. PangY. ZhuangJ. LinH. ZhangQ. HanL. KeP. ZhuangJ. HuangX. Selenepezil, a selenium-containing compound, exerts neuroprotective effect via modulation of the Keap1–Nrf2–ARE pathway and attenuates Aβ-induced cognitive impairment in vivo.ACS Chem. Neurosci.20191062903291410.1021/acschemneuro.9b0010631035749
     [Google Scholar]
  43. MaoF. ChenJ. ZhouQ. LuoZ. HuangL. LiX. Novel tacrine–ebselen hybrids with improved cholinesterase inhibitory, hydrogen peroxide and peroxynitrite scavenging activity.Bioorg. Med. Chem. Lett.201323246737674210.1016/j.bmcl.2013.10.03424220172
     [Google Scholar]
  44. de FreitasA.S. FunckV.R. RottaM.S. BohrerD. MörschbächerV. PuntelR.L. NogueiraC.W. FarinaM. AschnerM. RochaJ.B.T. Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice.Brain Res. Bull.2009791778410.1016/j.brainresbull.2008.11.00119047014
     [Google Scholar]
  45. LucheseC. PintonS. NogueiraC.W. Brain and lungs of rats are differently affected by cigarette smoke exposure: Antioxidant effect of an organoselenium compound.Pharmacol. Res.200959319420110.1016/j.phrs.2008.11.00619095064
     [Google Scholar]
  46. QuispeR.L. JaramilloM.L. GalantL.S. EngelD. DafreA.L. Teixeira da RochaJ.B. RadiR. FarinaM. de BemA.F. Diphenyl diselenide protects neuronal cells against oxidative stress and mitochondrial dysfunction: Involvement of the glutathione-dependent antioxidant system.Redox Biol.20192011812910.1016/j.redox.2018.09.01430308475
     [Google Scholar]
  47. GaiB.M. BortolattoC.F. HeckS.O. SteinA.L. DuarteM.M.M.F. ZeniG. NogueiraC.W. An organoselenium compound improves behavioral, endocrinal and neurochemical changes induced by corticosterone in mice.Psychopharmacology2014231102119213010.1007/s00213‑013‑3361‑924306280
     [Google Scholar]
  48. VictoriaF.N. AnversaR. PenteadoF. CastroM. LenardãoE.J. SavegnagoL. Antioxidant and antidepressant-like activities of semi-synthetic α-phenylseleno citronellal.Eur. J. Pharmacol.201474213113810.1016/j.ejphar.2014.09.00525218989
     [Google Scholar]
  49. BirmannP.T. CasarilA.M. HartwigD. JacobR.G. SeixasF.K. CollaresT. SavegnagoL. A novel pyrazole-containing selenium compound modulates the oxidative and nitrergic pathways to reverse the depression-pain syndrome in mice.Brain Res.2020174114688010.1016/j.brainres.2020.14688032417177
     [Google Scholar]
  50. BirmannP.T. DominguesM. CasarilA.M. SmaniottoT.Â. HartwigD. JacobR.G. SavegnagoL. A pyrazole-containing selenium compound modulates neuroendocrine, oxidative stress, and behavioral responses to acute restraint stress in mice.Behav. Brain Res.202139611287410.1016/j.bbr.2020.11287432835778
     [Google Scholar]
  51. ZborowskiV.A. HeckS.O. VencatoM. PintonS. MarquesL.S. NogueiraC.W. Keap1/Nrf2/HO-1 signaling pathway contributes to p-chlorodiphenyl diselenide antidepressant-like action in diabetic mice.Psychopharmacology2020237236337410.1007/s00213‑019‑05372‑331828396
     [Google Scholar]
  52. BampiS.R. CasarilA.M. FronzaM.G. DominguesM. VieiraB. BegniniK.R. SeixasF.K. CollaresT.V. LenardãoE.J. SavegnagoL. The selenocompound 1-methyl-3-(phenylselanyl)-1H-indole attenuates depression-like behavior, oxidative stress, and neuroinflammation in streptozotocin-treated mice.Brain Res. Bull.202016115816510.1016/j.brainresbull.2020.05.00832470357
     [Google Scholar]
  53. PosserT. KasterM.P. BaraúnaS.C. RochaJ.B.T. RodriguesA.L.S. LealR.B. Antidepressant-like effect of the organoselenium compound ebselen in mice: Evidence for the involvement of the monoaminergic system.Eur. J. Pharmacol.20096021859110.1016/j.ejphar.2008.10.05519026628
     [Google Scholar]
  54. BortolattoC.F. WilhelmE.A. ChagasP.M. NogueiraC.W. p-Chloro-diphenyl diselenide, an organoselenium compound, with antidepressant-like and memory enhancer actions in aging male rats.Biogerontology201213323724910.1007/s10522‑011‑9369‑922143824
     [Google Scholar]
  55. BrüningC.A. SouzaA.C.G. GaiB.M. ZeniG. NogueiraC.W. Antidepressant-like effect of m-trifluoromethyl-diphenyl diselenide in the mouse forced swimming test involves opioid and serotonergic systems.Eur. J. Pharmacol.20116582-314514910.1016/j.ejphar.2011.02.03921371464
     [Google Scholar]
  56. GerzsonM.F.B. VictoriaF.N. RadatzC.S. de GomesM.G. BoeiraS.P. JacobR.G. AlvesD. JesseC.R. SavegnagoL. In vitro antioxidant activity and in vivo antidepressant-like effect of α-(phenylselanyl) acetophenone in mice.Pharmacol. Biochem. Behav.20121021212910.1016/j.pbb.2012.03.01622484161
     [Google Scholar]
  57. SousaF.S.S. BirmannP.T. BaldinottiR. FronzaM.G. BalaguezR. AlvesD. BrüningC.A. SavegnagoL. α- (phenylselanyl) acetophenone mitigates reserpine-induced pain–depression dyad: Behavioral, biochemical and molecular docking evidences.Brain Res. Bull.201814212913710.1016/j.brainresbull.2018.07.00730016730
     [Google Scholar]
  58. BesckowE.M. NonemacherN.T. GarciaC.S. da Silva EspíndolaC.N. BalbomÉ.B. GritzencoF. SavegnagoL. GodoiB. BortolattoC.F. BrüningC.A. Antidepressant-like effect of a selenopropargylic benzamide in mice: Involvement of the serotonergic system.Psychopharmacology2020237103149315910.1007/s00213‑020‑05600‑132617647
     [Google Scholar]
  59. CasarilA.M. DominguesM. BampiS.R. de Andrade LourençoD. PadilhaN.B. LenardãoE.J. SonegoM. SeixasF.K. CollaresT. NogueiraC.W. DantzerR. SavegnagoL. The selenium-containing compound 3-((4-chlorophenyl)selanyl)-1-methyl-1H-indole reverses depressive-like behavior induced by acute restraint stress in mice: modulation of oxido-nitrosative stress and inflammatory pathway.Psychopharmacology2019236102867288010.1007/s00213‑018‑5151‑x30610349
     [Google Scholar]
  60. WilhelmE.A. JesseC.R. RomanS.S. BortolattoC.F. NogueiraC.W. Anticonvulsant effect of (E)-2-benzylidene-4-phenyl-1,3-diselenole in a pilocarpine model in mice.Life Sci.20108719-2262062710.1016/j.lfs.2010.09.02220888349
     [Google Scholar]
  61. WilhelmE.A. GaiB.M. SouzaA.C.G. BortolattoC.F. RoehrsJ.A. NogueiraC.W. Involvement of GABAergic and glutamatergic systems in the anticonvulsant activity of 3-alkynyl selenophene in 21 day-old rats.Mol. Cell. Biochem.20123651-217518010.1007/s11010‑012‑1257‑322350757
     [Google Scholar]
  62. ŁączkowskiKZ BiernasiukA Baranowska-ŁączkowskaA ZielińskaS SałatK FurgałaA MisiuraK MalmA Synthesis, antimicrobial and anticonvulsant screening of small library of tetrahydro-2 H-thiopyran-4-yl based thiazoles and selenazoles.J Enzyme Inhib Med Chem201631S2243910.1080/14756366.2016.1186020
     [Google Scholar]
  63. TorresDJ AlfulaijN BerryMJ Stress and the brain: An emerging role for selenium.Front Neurosci.20211566660110.3389/fnins.2021.666601
     [Google Scholar]
  64. IbrahimM. MussuliniB.H.M. MoroL. de AssisA.M. RosembergD.B. de OliveiraD.L. RochaJ.B.T. SchwabR.S. SchneiderP.H. SouzaD.O. RicoE.P. Anxiolytic effects of diphenyl diselenide on adult zebrafish in a novelty paradigm.Prog. Neuropsychopharmacol. Biol. Psychiatry20145418719410.1016/j.pnpbp.2014.06.00224936773
     [Google Scholar]
  65. DominguesM. CasarilA.M. BirmannP.T. BampiS.R. LourençoD.A. VieiraB.M. DapperL.H. LenardãoE.J. SonegoM. CollaresT. SeixasF.K. BrüningC.A. SavegnagoL. Effects of a selanylimidazopyridine on the acute restraint stress-induced depressive- and anxiety-like behaviors and biological changes in mice.Behav. Brain Res.20193669610710.1016/j.bbr.2019.03.02130877027
     [Google Scholar]
  66. ReisA.S. PinzM. DuarteL.F.B. RoehrsJ.A. AlvesD. LucheseC. WilhelmE.A. 4-phenylselenyl-7-chloroquinoline, a novel multitarget compound with anxiolytic activity: Contribution of the glutamatergic system.J. Psychiatr. Res.20178419119910.1016/j.jpsychires.2016.10.00727756019
     [Google Scholar]
  67. SampaioT.B. PintonS. da RochaJ.T. GaiB.M. NogueiraC.W. BDNF/TrkB signaling involvement in the effect of diphenyl diselenide on motor function in a Parkinson’s disease rat model.Eur. J. Pharmacol.2017795283510.1016/j.ejphar.2016.11.05427915043
     [Google Scholar]
  68. MoussaouiS. ObinuM.C. DanielN. ReibaudM. BlanchardV. ImperatoA. The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson’s disease.Exp. Neurol.2000166223524510.1006/exnr.2000.751611085889
     [Google Scholar]
  69. XuJ.H. HuH.T. LiuY. QianY.H. LiuZ.H. TanQ.R. ZhangZ.J. Neuroprotective effects of ebselen are associated with the regulation of Bcl-2 and Bax proteins in cultured mouse cortical neurons.Neurosci. Lett.2006399321021410.1016/j.neulet.2006.02.02416513270
     [Google Scholar]
  70. ElshafluH. TodorovićT.R. NikolićM. LolićA. VišnjevacA. HagenowS. PadrónJ.M. García-SosaA.T. DjordjevićI.S. GrubišićS. StarkH. FilipovićN.R. Selenazolyl-hydrazones as novel selective MAO inhibitors with antiproliferative and antioxidant activities: Experimental and in silico studies.Front Chem.2018624710.3389/fchem.2018.0024730018949
     [Google Scholar]
  71. ShayganfardM. Are essential trace elements effective in modulation of mental disorders? update and perspectives.Biol Trace Elem Res.202120031032105910.1007/s12011‑021‑02733‑y
     [Google Scholar]
  72. NogueiraC.W. BarbosaN.V. RochaJ.B.T. Toxicology and pharmacology of synthetic organoselenium compounds: An update.Arch. Toxicol.20219541179122610.1007/s00204‑021‑03003‑533792762
     [Google Scholar]
/content/journals/cis/10.2174/2210299X02666221027151154
Loading
Organoselenium Compounds as Potential Therapeutic Agents for Treating Brain Disorders
Curr. Indian Sci. 1, e271022210428 (2023); https://doi.org/10.2174/2210299X02666221027151154
/content/journals/cis/10.2174/2210299X02666221027151154
/content/journals/cis/10.2174/2210299X02666221027151154
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): Anti-Alzheimer activity; Anticonvulsant activity; Antidepressant activity; Antioxidant activity; Brain disorder; Neurodegenerative disorders; Organoselenium compound; Selenium

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test